Influence of Disease and Patient Characteristics on Daratumumab Exposure and Clinical Outcomes in Relapsed or Refractory Multiple Myeloma. uri icon

authors

  • Yan, Xiaoyu
  • Liu, Kevin
  • Orlowski, Robert Z
  • Losic, Nedjad
  • Jansson, Richard
  • Ahmadi, Tahamtan
  • Lantz, Kristen
  • Ruixo, Juan Jose Perez
  • Zhou, Honghui
  • Xu, Xu Steven
  • Clemens, Pamela L
  • Puchalski, Thomas
  • Lonial, Sagar
  • Lokhorst, Henk
  • Voorhees, Peter M
  • Usmani, Saad
  • Richardson, Paul G
  • Plesner, Torben

publication date

  • January 2018